Boehringer Ingelheim
Last updated on 2013-11-20T06:39+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| farmacêutica alemã | 40.00% | PT | 29/12/2016 |
| farmacêutica | 20.00% | PT | 24/05/2016 |
| manufacturer | 20.00% | EN | 23/03/2015 |
| german manufacturer | 20.00% | EN | 23/03/2015 |
| Names | Lang | Count |
|---|---|---|
| Boehringer Ingelheim | EN | 61.60% |
| Boehringer Ingelheim | FR | 14.81% |
| Boehringer Ingelheim Pharmaceuticals | EN | 3.55% |
| Boehringer Ingelheim | PT | 3.10% |
| Boehringer Ingelheim | ES | 2.34% |
| Boehringer Ingelheim | PL | 2.19% |
| Boehringer Ingelheim | DE | 2.19% |
| Boehringer Ingelheim | IT | 2.12% |
| Boehringer Ingelheim | EU | 2.04% |
| Boehringer Ingelheim | SV | 2.04% |
| Boehringer-Ingelheim | EN | 1.74% |
| Boehringer-Ingelheim | FR | 1.51% |
| Boehringer-Ingelheim Pharmaceuticals | EN | 0.23% |
| Boehringer Ingelheim | AR | 0.15% |
| BOEHRINGER INGELHEIM | EN | 0.08% |
| Boehringer-Ingelheim Pharmaceuticals | FR | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | PT | 0.08% |
| Boehringer Ingelheim Pharmaceuticals | ES | 0.08% |
| Boehringer-Ingelheim | DE | 0.08% |
| ベーリンガーインゲルハイム | JA | 0.00% |
| 勃林格殷格翰 | ZH | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Pfizer Inc | 4.69% |
| Inc | 4.59% |
| Bristol Myers Squibb | 2.83% |
 | Commission | 2.74% |
| European Union | 2.44% |
| European Medicines Agency | 2.35% |
| European Commission | 2.15% |
| Novartis | 2.05% |
| Wall Street | 1.86% |
| Yang | 1.66% |
| Novo Nordisk | 1.17% |
| Strategy | 0.98% |
| Bloomberg LP | 0.88% |
| Pharmaceuticals Inc | 0.88% |
| Association | 0.88% |
| Eli Lilly | 0.78% |
| 0.78% | |
| Priscilla VanderVeer | 0.68% |
| Charlie Baker | 0.68% |
| Ned Lamont | 0.68% |
| Cancer Research | 0.68% |
| CPI | 0.59% |
| Medicines Agency | 0.59% |
| Teva Pharmaceuticals | 0.59% |
| Samsung | 0.59% |
| GlaxoSmithKline | 0.59% |
| Alexander Novak | 0.59% |
| Risk Factors | 0.59% |
| Solutions | 0.59% |
| Taiwan Semiconductor | 0.49% |
| Type | Entity Name | Score |
|---|---|---|
| Bristol Myers Squibb | 0.0284 |
| Novartis | 0.0212 |
| Deisha Barnett | 0.0161 |
| Priscilla VanderVeer | 0.0147 |
| Thomas Hanke | 0.0145 |
| Yang | 0.0135 |
| Trish Taylor | 0.0135 |
| Novo Nordisk | 0.0124 |
| Pfizer Inc | 0.0113 |
| Inc | 0.0112 |
| Roch Doliveux | 0.011 |
| European Medicines Agency | 0.0103 |
| Werner Lanthaler | 0.0092 |
| Pharmaceuticals Inc | 0.009 |
| Eli Lilly | 0.0077 |
| Cancer Research | 0.0075 |
| Alexis Peyroles | 0.0073 |
| Nicolas Poirier | 0.0072 |
| Charlie Baker | 0.0069 |
| Ned Lamont | 0.0069 |
| Wall Street | 0.0066 |
| Esther Sciammarella | 0.0066 |
| Teva Pharmaceuticals | 0.006 |
| Alexander Novak | 0.006 |
| Risk Factors | 0.0057 |
| Strategy | 0.0055 |
| GlaxoSmithKline | 0.0054 |
| Bloomberg LP | 0.0052 |
| 0.0051 | |
| Samsung | 0.0048 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Thursday, April 22, 2021
6:10:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 